+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Oral Biologics & Biosimilars Global Market Report 2024 - Product Thumbnail Image

Oral Biologics & Biosimilars Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
Chronic Plaque Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Plaque Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Bipolar Disorder (Manic Depression) - Pipeline Insight, 2024 - Product Thumbnail Image

Bipolar Disorder (Manic Depression) - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 80 Pages
  • Global
From
From
Generic Central Nervous System Drugs Global Market Report 2024 - Product Thumbnail Image

Generic Central Nervous System Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Insulin biosimilars Global Market Report 2024 - Product Thumbnail Image

Insulin biosimilars Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Multiple Myeloma Global Market Report 2024 - Product Thumbnail Image

Multiple Myeloma Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Loading Indicator